Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Agios Pharmaceuticals, Inc.
Updated Jul 16, 2026
Smith Cynthia has filed 5 SEC Form 4 filings across 5 companies in the last 90 days.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-25 | SPRO | Spero Therapeutics, Inc. | A — Grant or award | 10.0K | $0.00 | |
| 2026-06-23 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.8K | $0.00 | |
| 2026-06-22 | AKBA | Akebia Therapeutics, Inc. | A — Grant or award | 35.7K | $0.00 | |
| 2025-08-11 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.3K | $0.00 |
Smith Cynthia is a corporate insider — currently tracked as Insider of Spero Therapeutics, Inc. (SPRO). InsiderAlpha tracks every SEC Form 4 filing in real time.
5 primary Form 4 filings in the last 90 days, covering 5 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Smith Cynthia profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.